MITF相关肾细胞癌的临床与分子特征
本文报道一例携带MITF p.E318K胚系变异的双侧多灶性1型乳头状肾细胞癌患者,家族中有肾癌史。肿瘤均携带该变异并伴7号和17号染色体扩增,且MiT家族下游靶点GPNMB表达失调。研究支持MITF变异为肾癌风险等位基因,并提示GPNMB可能作为生物标志物。
要点
- MITF p.E318K胚系变异与双侧多灶性1型乳头状肾细胞癌相关。
- 肿瘤均显示7号和17号染色体扩增,为1型乳头状肾细胞癌特征。
- GPNMB等MiT家族下游靶点在肿瘤中表达失调,或为潜在生物标志物。
核心结论
- MITF p.E318K变异与双侧多灶性1型乳头状肾细胞癌相关,支持其作为肾癌风险等位基因。
- 建议不论肾细胞癌组织学亚型均应筛查MITF变异。
- GPNMB表达失调可能作为MITF相关肾细胞癌的潜在生物标志物。
研究设计与样本
- 研究对一例双侧多灶性1型乳头状肾细胞癌且家族有肾癌史的患者进行临床、家族史、肿瘤组织病理和手术管理评估。
- 对血液DNA、肿瘤DNA及癌旁正常肾组织DNA进行测序。
- 通过实时聚合酶链反应对肿瘤和正常组织进行拷贝数和基因表达分析,并利用TCGA基因表达数据做比较分析。
- 通过免疫组化评估蛋白表达和亚细胞定位。
主要发现
- 胚系基因组分析发现患者携带MITF p.E318K变异。
- 所有肿瘤均显示MITF变异,并伴有7号和17号染色体扩增。
- MITF p.E318K变异导致转录活性改变,MiT家族下游靶点如GPNMB在肿瘤中表达失调。
临床怎么用
- 对双侧多灶性肾细胞癌或有肾癌家族史的患者,应考虑筛查MITF胚系变异。
- MITF变异筛查不应受肾细胞癌组织学亚型限制。
- GPNMB表达可能有助于识别MITF相关肾细胞癌,并为靶向治疗开发提供方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To characterize the clinical presentation, genomic alterations, pathologic phenotype and clinical management of microphthalmia-associated transcription factor (MITF) familial renal cell carcinoma (RCC), caused by a member of the TFE3, TFEB, and MITF family of transcription factor genes. METHODS: The clinical presentation, family history, tumor histopathology, and surgical management were evaluated and reported herein. DNA sequencing was performed on blood DNA, tumor DNA and DNA extracted from adjacent normal kidney tissue. Copy number and gene expression analyses on tumor and normal tissues were performed by Real-Time Polymerase chain reaction. TCGA gene expression data were used for comparative analysis. Protein expression and subcellular localization were evaluated by immunohistochemistry. RESULTS: Germline genomic analysis identified the MITF p.E318K variant in a patient with bilateral, multifocal type 1 papillary RCC and a family history of RCC. All tumors displayed the MITF variant and were characterized by amplification of chromosomes 7 and 17, hallmarks of type 1 papillary RCC. We demonstrated that MITF p.E318K variant results in altered transcriptional activity and that downstream targets of MiT family members, such as GPNMB, are dysregulated in the tumors. CONCLUSION: Association of the pathogenic MITF variant with bilateral and multifocal type 1 papillary RCC in this family supports its role as a risk allele for the development of RCC and emphasizes the importance of screening for MITF variants irrelevant of the RCC histologic subtype. This study identifies potential biomarkers for the disease, such as GPNMB expression, that may facilitate the development of targeted therapies for patients affected with MITF-associated RCC.
引用
- Lang M, Vocke CD, Ricketts CJ, et al. Clinical and Molecular Characterization of Microphthalmia-associated Transcription Factor (MITF)-related Renal Cell Carcinoma. Urology. 2020. PMID: 33242557. doi:10.1016/j.urology.2020.11.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。